How Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
3 years agoHow Has The Covid-19 Pandemic Impacted Oncology and Clinical Operations?
As a part of Proventa’s Clinical Operations and Oncology Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Tanya Russel Kirkpatrick, VP Clinical...
3 years ago
AstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns
In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...
3 years agoAstraZeneca/Alexion Purchase Held Up by CMA Amid Concerns
In December 2020, pharma giant AstraZeneca (AZ) announced its intention to acquire biopharmaceutical company Alexion. The merger would give AZ an increased portfolio in rare disease and immunology. While the US Federal Trade Commission (FTC) has approved the merger, several...
3 years ago
The Great Debate: The Utilisation of True AI in All Aspects of Drug Discovery
As a part of Proventa’s Medicinal Chemistry and Biology Strategy Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Gilead’s Executive Director for...
3 years agoThe Great Debate: The Utilisation of True AI in All Aspects of Drug Discovery
As a part of Proventa’s Medicinal Chemistry and Biology Strategy Meeting May 2021, we organised a number of interesting keynote sessions pondering the latest innovations, challenges and strategies for the future. The morning keynote, hosted by Gilead’s Executive Director for...
3 years ago
Biomarker Discovery and Validation: Current Challenges in Oncology
Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...
3 years agoBiomarker Discovery and Validation: Current Challenges in Oncology
Biomarkers have shown significant potential across oncology clinical studies, especially in precision medicine for immunotherapy. Therefore, it is important that biomarker discovery and validation is optimised to produce the most effective drugs for patient populations. False positives and experimental bias...
3 years ago
First Potential Alzheimer’s Drug on the Brink of FDA Approval
On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...
3 years agoFirst Potential Alzheimer’s Drug on the Brink of FDA Approval
On 7 June 2021, Biogen will receive an answer from the FDA regarding the approval of their Alzheimer’s drug, Aducanumab. Approval for this drug will represent a significant milestone in disease management for Alzheimer’s patients, in terms of slowing the...
3 years ago
Supporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
3 years agoSupporting Diversity in Clinical Trials: An Interview with Ash Rishi, COUCH Health
COVID-19 has changed how many sponsors enrol and retain trial participants. From decentralisation, increased use of wearables and changes in population targeting, the pandemic has seen a shift in both priorities and procedures with regard to enrolment. But is this...
3 years ago
Exploring the Latest Therapeutic Tools and In Vitro Technologies
Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...
3 years agoExploring the Latest Therapeutic Tools and In Vitro Technologies
Preclinical studies are an integral part of drug development in terms of screening drug candidates for therapeutic efficacy and potential toxic events. 3D culture and organ-on-chip technology are a few examples of the innovations in in vitro/in vivo modelling to...
3 years ago
Emerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years agoEmerging Therapeutics in Translational Medicine: Nanotechnology
Hear from some of the industry leaders including David Cook, Chief Scientific Officer, Blueberry Therapeutics who will be providing his expertise in leading a discussion on using translational research techniques to improve drug development. For daily articles on the latest pharma...
3 years ago
The Opportunities and Challenges of Remote Patient Monitoring
The success of decentralised clinical trials during the pandemic was dependent on telemedicine to monitor patient health and collect data. Actigraphy bracelets and video consultations are a few examples of how patients can be monitored remotely for healthcare and data...
3 years agoThe Opportunities and Challenges of Remote Patient Monitoring
The success of decentralised clinical trials during the pandemic was dependent on telemedicine to monitor patient health and collect data. Actigraphy bracelets and video consultations are a few examples of how patients can be monitored remotely for healthcare and data...
3 years ago
The Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years agoThe Latest Developments in Precision Oncology
Precision medicine is a rapidly growing therapeutic area within oncology. Technological innovations have contributed to the refinement of predictive and diagnostic techniques used to tailor therapy for cancer patients. The goal is to not only develop more precise treatments, but...
3 years ago